Contact Information
Company Information
Company
Vico Therapeutics
Total Funding
103295225.0
Technologies
Outlook
Microsoft Office 365
Google Maps
Vimeo
Shutterstock
Google Font API
WordPress.org
reCAPTCHA
Nginx
Google Tag Manager
AddThis
Google Analytics
Mobile Friendly
Basis
AI
Keywords
biotechnology research
rna therapies
antisense oligonucleotides
neurodegenerative diseases
huntington's disease
spinocerebellar ataxia
polyglutamine disorders
gene targeting
molecular neuroscience
clinical development
allele-preferential targeting
cag repeat expansion
therapeutic development
drug discovery
biotechnology
neuroscience research
genetic medicine
csf biomarkers
huntingtin-lowering therapy
precision medicine
patient outcomes
clinical trials
rare genetic disorders
mhtt reduction
nucleoside chemistry
oligonucleotide synthesis
therapeutic innovation
drug pipeline
first-in-class therapies
safety & tolerability
chd modulating therapies
biopharmaceuticals
clinical-stage therapies
preclinical studies
patient-centric approach
investigational medicines
neuroprotective strategies
molecular therapeutics
neurological pathology
neurodegeneration
healthcare investment
biotech investment
research collaborations
orphan drug designation
multidisciplinary teams
biotech ecosystem
therapeutic strategies
clinical endpoints
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans